A AddLife AB
A
Fermé
158.4 -1.8
Résumé
Variation du prix de l'action
24h
Min
156.2
Max
161.9
Revenu | -31M 229M |
|---|---|
Ventes | -88M 2.6B |
P/E Moyenne du Secteur | 33.72 99.973 |
BPA | 1.04 |
Rendement du dividende | 0.95 |
Marge bénéficiaire | 8.658 |
Employés | 2,295 |
EBITDA | -373M 229M |
Rendement du dividende Moyenne du Secteur | 0.95% 2.44% |
|---|
Capitalisation Boursière | 1.5B 19B |
|---|---|
Ouverture précédente | 160.2 |
Clôture précédente | 158.4 |
AddLife AB Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
À Propos AddLife AB
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
